Skip to main content
Back
PBH logo

Prestige Consumer Healthcare Inc.

Data quality: 100%
PBH
NYSE Healthcare Medical - Distribution
$61.13
▼ $0.87 (-1.40%)
Mkt Cap: 2.94B
Day Range
$60.45 $63.02
52-Week Range
$57.25 $89.37
Volume
269,342
50D / 200D Avg
$65.70 / $67.08
Prev Close
$62.00

Quick Summary

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (631 peers)

Metric Stock Sector Median
P/E 13.7 0.2
P/B 1.6 3.0
ROE % 12.3 3.6
Net Margin % 18.9 3.8
Rev Growth 5Y % 4.8 9.9
D/E 0.6 0.2

Analyst Price Target

Hold
$66.00 +8.0%
Forward P/E
13.46
Forward EPS
$4.54
EPS Growth (est.)
+0.0%
Est. Revenue
1.10B

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2030 $5.30
$5.26 – $5.39
 1.16B 1
FY2029 $5.12
$5.08 – $5.20
 1.14B 1
FY2028 $5.03
$4.99 – $5.07
 1.15B 2

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-05 $1.14 $1.14 0.0%
2025-11-06 $0.97 $1.07 +10.3%
2025-08-07 $1.01 $0.95 -5.9%
2025-05-08 $1.30 $1.32 +1.5%
2025-02-06 $1.16 $1.22 +5.2%
2024-11-07 $1.08 $1.09 +0.9%
2024-08-08 $0.86 $0.90 +4.7%
2024-05-14 $1.14 $0.98 -14.0%

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

Ex-Date Payment Date Amount Yield
Sep 27, 2018 Oct 15, 2018 $0.48 1.25%
Dec 27, 2013 — $0.31 0.87%

Key Takeaways

Revenue grew 4.80% annually over 5 years — modest growth
ROE of 12.30% — decent returns on equity
Net margin of 18.86% shows strong profitability
Generating 243.29M in free cash flow
P/E of 13.70 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.70%

Growth

Revenue Growth (5Y)
4.80%
Revenue (1Y)1.10%
Earnings (1Y)2.52%
FCF Growth (3Y)4.70%

Quality

Return on Equity
12.30%
ROIC8.77%
Net Margin18.86%
Op. Margin29.60%

Safety

Debt / Equity
0.57
Current Ratio4.20
Interest Coverage7.07

Valuation

P/E Ratio
13.70
Forward P/E13.46
P/B Ratio1.60
EV/EBITDA11.54
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 1.10% Revenue Growth (3Y) 0.44%
Earnings Growth (1Y) 2.52% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 4.80% Earnings Growth (5Y) 6.84%
Profitability
Revenue (TTM) 1.14B Net Income (TTM) 214.61M
ROE 12.30% ROA 6.31%
Gross Margin 55.76% Operating Margin 29.60%
Net Margin 18.86% Free Cash Flow (TTM) 243.29M
ROIC 8.77% FCF Growth (3Y) 4.70%
Safety
Debt / Equity 0.57 Current Ratio 4.20
Interest Coverage 7.07
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 13.70 Forward P/E 13.46
P/B Ratio 1.60 P/S Ratio 2.58
PEG Ratio 7.62 Forward PEG N/A
EV/EBITDA 11.54 Fwd EV/EBITDA 13.32
Forward P/S 2.67 Fwd Earnings Yield 7.43%
FCF Yield 8.28%
Market Cap 2.94B Enterprise Value 3.89B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.14B 1.13B 1.13B 1.09B 943.37M
Net Income 214.61M 209.34M -82.31M 205.38M 164.68M
EPS (Diluted) 4.29 4.17 -1.65 4.04 3.25
Gross Profit 634.46M 624.45M 625.29M 620.65M 547.47M
Operating Income 336.78M 342.43M -22.42M 329.92M 297.40M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 3.40B 3.32B 3.35B 3.67B 3.43B
Total Liabilities 1.57B 1.66B 1.91B 2.09B 2.07B
Shareholders' Equity 1.83B 1.66B 1.45B 1.58B 1.36B
Total Debt 1.04B 1.14B 1.37B 1.51B 1.51B
Cash & Equivalents 97.88M 46.47M 58.49M 27.19M 32.30M
Current Assets 448.33M 375.04M 391.74M 293.27M 269.84M
Current Liabilities 106.62M 117.05M 160.72M 143.42M 122.14M